News FDA approves first treatment for children with lupus The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus.
News AZ's lupus drug fails in late-stage trial AZ will launch full review after further phase 3 results later this year
News Gilead to collaborate with Google’s Verily in inflammatory d... Gilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological and molecular drivers behind three inflammatory diseases.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.